News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
203,075 Results
Type
Article (9484)
Company Profile (121)
Press Release (193466)
Multimedia
Podcasts (85)
Webinars (16)
Section
Business (58403)
Career Advice (428)
Deals (10555)
Drug Delivery (40)
Drug Development (34434)
Employer Resources (76)
FDA (3421)
Job Trends (4749)
News (105351)
Policy (7760)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (374)
Accelerated approval (22)
Adcomms (4)
Allergies (70)
Alliances (13430)
ALS (79)
Alzheimer's disease (585)
Antibody-drug conjugate (ADC) (228)
Approvals (3635)
Artificial intelligence (227)
Autoimmune disease (131)
Automation (12)
Bankruptcy (72)
Best Places to Work (3640)
BIOSECURE Act (16)
Biosimilars (132)
Biotechnology (77)
Bladder cancer (68)
Brain cancer (28)
Breast cancer (209)
Cancer (2188)
Cardiovascular disease (144)
Career advice (402)
Career pathing (36)
CAR-T (135)
CDC (19)
Celiac Disease (1)
Cell therapy (322)
Cervical cancer (14)
Clinical research (31164)
Collaboration (788)
Compensation (776)
Complete response letters (39)
COVID-19 (810)
CRISPR (32)
C-suite (531)
Cystic fibrosis (45)
Data (3277)
Decentralized trials (1)
Denatured (14)
Depression (81)
Dermatology (33)
Diabetes (175)
Diagnostics (877)
Digital health (12)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (79)
Drug pricing (67)
Drug shortages (4)
Duchenne muscular dystrophy (93)
Earnings (26751)
Editorial (52)
Employer branding (10)
Employer resources (65)
Events (41857)
Executive appointments (506)
FDA (4782)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (557)
Gene editing (68)
Generative AI (21)
Gene therapy (216)
GLP-1 (404)
Government (1051)
Grass and pollen (1)
Guidances (153)
Healthcare (3100)
HIV (40)
Huntington's disease (13)
IgA nephropathy (28)
Immunology and inflammation (106)
Immuno-oncology (44)
Indications (90)
Infectious disease (917)
Inflammatory bowel disease (88)
Inflation Reduction Act (8)
Influenza (28)
Intellectual property (108)
Interviews (76)
IPO (6061)
IRA (20)
Job creations (1123)
Job search strategy (302)
JPM (36)
Kidney cancer (14)
Labor market (89)
Layoffs (198)
Leadership (36)
Legal (1155)
Liver cancer (35)
Longevity (5)
Lung cancer (374)
Lymphoma (190)
Machine learning (23)
Management (24)
Manufacturing (414)
MASH (128)
Medical device (866)
Medtech (875)
Mergers & acquisitions (5057)
Metabolic disorders (583)
mRNA (67)
Multiple sclerosis (83)
NASH (12)
Neurodegenerative disease (138)
Neuropsychiatric disorders (48)
Neuroscience (1190)
NextGen: Class of 2026 (1279)
Non-profit (497)
Now hiring (65)
Obesity (262)
Opinion (131)
Ovarian cancer (75)
Pain (69)
Pancreatic cancer (87)
Parkinson's disease (107)
Partnered (4)
Patents (181)
Patient recruitment (278)
Peanut (23)
People (19670)
Pharmaceutical (37)
Pharmacy benefit managers (5)
Phase 1 (9355)
Phase 2 (14119)
Phase 3 (10704)
Pipeline (3597)
Policy (156)
Postmarket research (625)
Preclinical (3598)
Press Release (19)
Prostate cancer (101)
Psychedelics (23)
Radiopharmaceuticals (154)
Rare diseases (404)
Real estate (1402)
Recruiting (33)
Regulatory (7570)
Reports (34)
Research institute (402)
Resumes & cover letters (47)
RNA editing (7)
RSV (32)
Schizophrenia (131)
Series A (96)
Series B (61)
Service/supplier (4)
Sickle cell disease (38)
Special edition (26)
Spinal muscular atrophy (74)
Sponsored (7)
Startups (1066)
State (1)
Stomach cancer (3)
Supply chain (30)
Tariffs (48)
The Weekly (70)
Vaccines (302)
Venture capital (58)
Weight loss (133)
Women's health (31)
Worklife (17)
Date
Today (45)
Last 7 days (345)
Last 30 days (1339)
Last 365 days (11867)
2026 (4814)
2025 (11971)
2024 (13486)
2023 (15372)
2022 (17697)
2021 (19144)
2020 (16495)
2019 (11604)
2018 (8409)
2017 (9789)
2016 (8293)
2015 (10507)
2014 (7978)
2013 (5916)
2012 (5774)
2011 (5731)
2010 (5599)
Location
Africa (201)
Alabama (21)
Arizona (44)
Arkansas (2)
Asia (16068)
Australia (1802)
California (5462)
Canada (1054)
China (899)
Colorado (220)
Connecticut (241)
Delaware (228)
Europe (28529)
Florida (742)
Georgia (152)
Hawaii (1)
Idaho (6)
Illinois (317)
India (41)
Indiana (207)
Iowa (14)
Japan (243)
Kansas (77)
Kentucky (13)
Louisiana (3)
Maine (4)
Maryland (530)
Massachusetts (4176)
Michigan (57)
Minnesota (180)
Mississippi (2)
Missouri (35)
Montana (2)
Nebraska (7)
Nevada (32)
New Hampshire (9)
New Jersey (1760)
New Mexico (7)
New York (1631)
North Carolina (676)
Northern California (2936)
Ohio (145)
Oklahoma (7)
Oregon (14)
Pennsylvania (919)
Puerto Rico (15)
Rhode Island (15)
South America (242)
South Carolina (8)
Southern California (2079)
Tennessee (29)
Texas (585)
United States (18501)
Utah (109)
Virginia (116)
Washington D.C. (24)
Washington State (343)
West Virginia (1)
Wisconsin (26)
203,075 Results for "sun biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Sun Pharma recalls cancer drug after finding glass particles in some vials
A batch of a chemotherapy product made at a Sun facility with a history of quality and compliance issues is being withdrawn from the U.S. market.
May 15, 2026
·
2 min read
·
Nick Paul Taylor
Deals
Sun Pharma beams up Organon in $11.75B acquisition
Sun Pharmaceutical is bringing Merck spinoff Organon into the fold, paying $11.75 billion in hopes of becoming a top global biosimilar player.
April 27, 2026
·
1 min read
·
Gabrielle Masson
Career Advice
The top 12 companies hiring in biopharma now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
May 7, 2026
·
1 min read
·
Angela Gabriel
Press Releases
Sun Pharma signs Definitive Agreement to Acquire Organon
April 26, 2026
·
11 min read
Obesity
Obesity ends oncology’s long reign as top contributor to biopharma pipeline value
In its latest biopharma pipeline report, Deloitte warned that the growing importance of a small pool of potential mega-blockbusters raises the risk of “significant value destruction from a single program failure.”
May 4, 2026
·
2 min read
·
Nick Paul Taylor
Artificial intelligence
Novartis CEO joins Anthropic board, embedding AI in the heart of biopharma
In recent months, Anthropic has been building more and more ties with the biopharma industry, including partnerships with Big Pharma companies such as Sanofi, Novo Nordisk and AbbVie.
April 16, 2026
·
2 min read
·
Tristan Manalac
Leadership
The 4 biggest hiring mistakes biopharma executives keep making
Finding the right people for critical open roles can be difficult even for biopharma leaders. In this column, Kaye/Bassman’s Michael Pietrack discusses four pitfalls executives face during the hiring process, starting with confusing scientific brilliance with leadership ability.
April 22, 2026
·
5 min read
·
Michael Pietrack
Venture capital
Biotech has become a good news story. Let the sun shine
Doubling survival in pancreatic cancer, a long-fought rare disease approval, a massive IPO and ambitious biotech entrepreneurs have
BioSpace
Senior Editor Annalee Armstrong feeling upbeat about the biotech scene.
April 20, 2026
·
2 min read
·
Annalee Armstrong
FDA
FDA’s CRL transparency policy is boosting biopharma accountability
Since the FDA began publishing its rejections of drug approval filings in July last year, companies have become more forthcoming about the details of agency decisions in their own disclosures, according to biopharma and regulatory analysts.
April 13, 2026
·
5 min read
·
Nick Paul Taylor
Job Trends
Report: Biopharma Job Market Report Q1 2026
BioSpace’s Biopharma Job Market Report reveals early signs of recovery for 2026. A rise in job postings, a surge in contract roles and strong M&A and IPO activity point to future hiring growth and shifts in hiring strategy.
April 9, 2026
·
1 min read
·
BioSpace Insights
1 of 20,308
Next
